Structural identification and presence of some p-menth-1-enediols in grape products

The present work aims at clearing the structure of some p-menthenediols, which are already known to be present in musts and wines as glycosides, referred to as isomers 1, 2 and 3. Isomers 2 and 3 correspond to cis-p-menth-1-ene-6,8-diol and p-menth-1-ene-7,8-diol; isomer 1, which is only found in traces, is probably identical with trans- p-menth-1-ene-6,8-diol. Their concentration is reported for both free and bound forms in musts from some varieties and compared with the alpha-terpineol and 2-exo-hydroxy-1,8-cineole concentrations. In general, the free forms were scarcely present; among the bound forms p-menth-1-ene-7,8-diol first and then cis-p-menth-1-ene-6,8-diol prevailed. Besides improvement of varietal classification, the compounds identified give evidence of allylic hydroxylase activity in grape berries

Identification of two stilbenoids from Vitis roots

Two oligostilbenes were isolated from roots of Vitis vinifera cv. Chardonnay and their structures were identified. One compound, ampelopsin A, is a dimer of resveratrol and has been found previously only in the roots of Ampelopsis brevipedunculata var. hancei (Vitaceae). The second, hopeaphenol, can be regarded as a dimer of ampelopsin A; its presence in Vitaceae is reported here for the first time. Both compounds are present in mg per g levels in vine roots

Larga batalla de un paciente con sida y tuberculosis recurrente: ¿reinfección o reactivación?

The advent of Mycobacterium tuberculosis strain genotyping has allowed differentiation between disease relapse and exogenous re-infection. We report here a remarkable case of multiply recurrent tuberculosis in a patient living with HIV. Between 1995 and 2009, a young HIV-infected intravenous drug user, who was reluctant to comply with anti-retroviral treatment, underwent at least five tuberculosis episodes caused by three distinct M. tuberculosis strains sharply differentiated by drug susceptibility profile, genotype and infectious source. Eventually, the patient died during a relapse of tuberculosis due to a notorious multidrug-resistant outbreak-strain, which infected him during a prolonged hospitalization in the epicentre of such outbreak. Whether recurrent tuberculosis is due to a new infection or to reactivation of a previous one is a century-long controversial question. In our patient, both conditions alternated throughout his 15 years of living with HIV. Cases such as this might not be exceptional in certain underprivileged suburban areas of Argentina and should raise concern over three pending issues in tuberculosis control policies, namely secondary preventive therapy, institutional infection control and patient follow-up throughout the health network system.La genotipificación de aislamientos clínicos de Mycobacterium tuberculosis permite diferenciar entre recaída y reinfección exógena. Presentamos un notable caso de tuberculosis recurrente asociado a sida. Entre 1995 y 2009, un usuario de drogas ilegales por vía endovenosa, con infección por el VIH pero reacio al tratamiento antirretroviral, sufrió cinco episodios de tuberculosis causados por tres cepas de M. tuberculosis. Las cepas se diferenciaron por los genotipos, los perfiles de sensibilidad a antibióticos y las fuentes de infección. El paciente murió de tuberculosis por una cepa multirresistente, responsable de un extenso brote en Argentina, que lo infectó durante una prolongada internación en el hospital que fue el epicentro de dicho brote. La controversia sobre el origen de la tuberculosis recurrente –reinfección o reactivación– lleva ya un siglo y continúa vigente. En el caso que aquí se describe, las dos situaciones se alternaron a lo largo de los 15 años de lucha contra el sida que atravesó este paciente. Esta situación puede no ser excepcional en áreas suburbanas desfavorecidas de Argentina, y pone en evidencia tres temas insuficientemente atendidos en nuestro medio: el tratamiento preventivo de la tuberculosis secundaria, el control de su transmisión en hospitales y cárceles, y el seguimiento de los pacientes a través del sistema de salud.Fil: Reniero, A.. Hospital Municipal de San Isidro; ArgentinaFil: Beltrán, M.. Hospital Municipal de San Isidro; ArgentinaFil: de Kantor, I. N.. PAHO/WHO consultant; ArgentinaFil: Ritacco, Gloria Viviana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentin

Larga batalla de un paciente con sida y tuberculosis recurrente: ¿reinfección o reactivación?

The advent of Mycobacterium tuberculosis strain genotyping has allowed differentiation between disease relapse and exogenous re-infection. We report here a remarkable case of multiply recurrent tuberculosis in a patient living with HIV. Between 1995 and 2009, a young HIV-infected intravenous drug user, who was reluctant to comply with anti-retroviral treatment, underwent at least five tuberculosis episodes caused by three distinct M. tuberculosis strains sharply differentiated by drug susceptibility profile, genotype and infectious source. Eventually, the patient died during a relapse of tuberculosis due to a notorious multidrug-resistant outbreak-strain, which infected him during a prolonged hospitalization in the epicentre of such outbreak. Whether recurrent tuberculosis is due to a new infection or to reactivation of a previous one is a century-long controversial question. In our patient, both conditions alternated throughout his 15 years of living with HIV. Cases such as this might not be exceptional in certain underprivileged suburban areas of Argentina and should raise concern over three pending issues in tuberculosis control policies, namely secondary preventive therapy, institutional infection control and patient follow-up throughout the health network system.La genotipificación de aislamientos clínicos de Mycobacterium tuberculosis permite diferenciar entre recaída y reinfección exógena. Presentamos un notable caso de tuberculosis recurrente asociado a sida. Entre 1995 y 2009, un usuario de drogas ilegales por vía endovenosa, con infección por el VIH pero reacio al tratamiento antirretroviral, sufrió cinco episodios de tuberculosis causados por tres cepas de M. tuberculosis. Las cepas se diferenciaron por los genotipos, los perfiles de sensibilidad a antibióticos y las fuentes de infección. El paciente murió de tuberculosis por una cepa multirresistente, responsable de un extenso brote en Argentina, que lo infectó durante una prolongada internación en el hospital que fue el epicentro de dicho brote. La controversia sobre el origen de la tuberculosis recurrente –reinfección o reactivación– lleva ya un siglo y continúa vigente. En el caso que aquí se describe, las dos situaciones se alternaron a lo largo de los 15 años de lucha contra el sida que atravesó este paciente. Esta situación puede no ser excepcional en áreas suburbanas desfavorecidas de Argentina, y pone en evidencia tres temas insuficientemente atendidos en nuestro medio: el tratamiento preventivo de la tuberculosis secundaria, el control de su transmisión en hospitales y cárceles, y el seguimiento de los pacientes a través del sistema de salud.Fil: Reniero, A.. Hospital Municipal de San Isidro; ArgentinaFil: Beltrán, M.. Hospital Municipal de San Isidro; ArgentinaFil: de Kantor, I. N.. PAHO/WHO consultant; ArgentinaFil: Ritacco, Gloria Viviana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentin

Prenatal exposures and exposomics of asthma

This review examines the causal investigation of preclinical development of childhood asthma using exposomic tools. We examine the current state of knowledge regarding early-life exposure to non-biogenic indoor air pollution and the developmental modulation of the immune system. We examine how metabolomics technologies could aid not only in the biomarker identification of a particular asthma phenotype, but also the mechanisms underlying the immunopathologic process. Within such a framework, we propose alternate components of exposomic investigation of asthma in which, the exposome represents a reiterative investigative process of targeted biomarker identification, validation through computational systems biology and physical sampling of environmental medi